Your browser is no longer supported. Please, upgrade your browser.
Settings
CSBR iShares MSCI Brazil UCITS ETF USD (Acc) daily Stock Chart
CSBR [NASD]
iShares MSCI Brazil UCITS ETF USD (Acc)
Index- P/E11.57 EPS (ttm)0.36 Insider Own10.20% Shs Outstand10.76M Perf Week0.72%
Market Cap45.30M Forward P/E- EPS next Y- Insider Trans0.47% Shs Float7.83M Perf Month1.94%
Income3.70M PEG- EPS next Q- Inst Own40.10% Short Float0.32% Perf Quarter18.26%
Sales19.00M P/S2.38 EPS this Y46.40% Inst Trans5.73% Short Ratio0.97 Perf Half Y14.71%
Book/sh0.04 P/B105.25 EPS next Y- ROA-46.60% Target Price- Perf Year69.08%
Cash/sh0.10 P/C41.18 EPS next 5Y- ROE-851.60% 52W Range2.19 - 4.75 Perf YTD8.51%
Dividend- P/FCF- EPS past 5Y21.90% ROI- 52W High-11.37% Beta-0.95
Dividend %- Quick Ratio0.70 Sales past 5Y16.60% Gross Margin45.70% 52W Low92.24% ATR0.16
Employees60 Current Ratio0.70 Sales Q/Q41.70% Oper. Margin-16.70% RSI (14)53.14 Volatility3.67% 3.71%
OptionableNo Debt/Eq0.00 EPS Q/Q590.20% Profit Margin-17.20% Rel Volume0.51 Prev Close4.12
ShortableYes LT Debt/Eq0.00 EarningsJun 14 AMC Payout- Avg Volume25.88K Price4.21
Recom- SMA20-2.30% SMA505.05% SMA20014.69% Volume13,172 Change2.18%
May-03-18 08:30AM  Champions Oncology to Present at the 3rd annual Disruptive Growth & Healthcare Conference on May 9th PR Newswire
May-01-18 08:30AM  Champions Oncology Adds Amy Wesa, Ph.D, as Director of Immuno-Oncology Research PR Newswire
Apr-04-18 08:30AM  Champions Oncology to Present at The MicroCap Conference on April 10th in New York City at the Essex House PR Newswire
Mar-28-18 07:10AM  Blog Exposure - Lexicon Announced NDA and MAA Submissions for Sotagliflozin to Treat Adults with Type-1 Diabetes ACCESSWIRE
Mar-15-18 04:01PM  Champions Oncology Reports Quarterly Revenue of $5.1 Million PR Newswire +7.10%
12:45PM  Champions Oncology, Inc. to Host Earnings Call ACCESSWIRE
08:46AM  Does Champions Oncology Incs (NASDAQ:CSBR) Past Performance Indicate A Stronger Future? Simply Wall St.
Mar-07-18 08:30AM  Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 15, 2018 PR Newswire
Feb-27-18 07:19PM  How Financially Strong Is Champions Oncology Inc (NASDAQ:CSBR)? Simply Wall St.
Feb-26-18 08:30AM  Champions Oncology to Participate at the 30th Annual ROTH Conference PR Newswire
Feb-21-18 08:30AM  Motivated Patients with ROS1 Cancer Initiate Global Research Study PR Newswire
Feb-14-18 06:29PM  February Insights Into Healthcare Stocks: Champions Oncology Inc (NASDAQ:CSBR) Simply Wall St. +6.05%
Dec-29-17 05:45PM  Why Champions Oncology Incs (NASDAQ:CSBR) CEO Pay Matters To You Simply Wall St.
Dec-19-17 09:16AM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q2, 2018 By the Numbers : December 19, 2017 Capital Cube
Dec-18-17 07:40AM  Blog Exposure - FDA Granted Tentative Approval for Expanded Label for Egalets ARYMO ER Extended-Release Tablets C-II ACCESSWIRE
Dec-07-17 04:15PM  Champions Oncology Reports Record Quarterly Revenue of $5.2 Million PR Newswire +7.06%
06:23AM  Was Champions Oncology Incs (CSBR) Earnings Growth Better Than Industry? Simply Wall St.
Nov-28-17 08:05AM  Champions Oncology to Announce Second Quarter Financial Results on Thursday, December 7, 2017 PR Newswire
Nov-27-17 04:01PM  Champions Oncology to Present at 10th Annual Main Event on December 5 ACCESSWIRE
05:50AM  Champions Oncology Inc (CSBR): Time For A Financial Health Check Simply Wall St.
Nov-07-17 08:00AM  Champions Oncology to Participate in the Craig-Hallum Alpha Select Investor Conference PR Newswire
Oct-12-17 12:34PM  Champions Oncology Inc (CSBR) And The Healthcare Industry Prospect For 2017 Simply Wall St.
Sep-26-17 08:30AM  Champions Oncology announces $2 million award from the National Cancer Institute (NCI) to develop and evaluate prostate cancer PDX models PR Newswire
Sep-18-17 02:14PM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q1, 2018 By the Numbers : September 18, 2017 Capital Cube +5.28%
09:15AM  Champions Oncology announces publication highlighting clinical correlation between patient-derived xenograft (PDX) model responses and patient responses to oncology therapies PR Newswire
Sep-14-17 04:30PM  Champions Oncology Reports Record Quarterly Revenue of $5 Million PR Newswire -5.29%
Sep-07-17 05:00PM  Champions Oncology to Announce First Quarter Financial Results on Thursday, September 14, 2017 PR Newswire
Aug-21-17 08:30AM  Champions Oncology Announces Strategic Collaboration with AstraZeneca to Develop Unique Cohorts of Patient-Derived Xenograft (PDX) Models PR Newswire +6.27%
Aug-18-17 08:30AM  Champions Oncology Announces Research Collaboration with The Addario Lung Cancer Medical Institute to Develop Unique Cohort of Patient-Derived Xenograft (PDX) Models PR Newswire
Aug-15-17 04:57AM  The Addario Lung Cancer Medical Institute, Champions Oncology and Motivated Patients Announce a Research Collaboration and Launch of a Patient Driven Clinical Study in ROS1 Positive Cancer PR Newswire
Aug-04-17 07:20AM  Corporate News Blog - Theravance Biopharmas Velusetrag Successful in Mid-Stage Gastroparesis Study ACCESSWIRE
Aug-01-17 10:07AM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q4, 2017 By the Numbers : August 1, 2017 Capital Cube +10.92%
Jul-27-17 04:01PM  Champions Oncology Reports 38% Revenue Growth for Fiscal Year Ended April 30, 2017 PR Newswire
Jul-17-17 08:30AM  Champions Oncology Schedules Fourth Quarter and Fiscal Year 2017 Earnings Call PR Newswire
Mar-23-17 01:04PM  CHAMPIONS ONCOLOGY, INC. Financials +6.04%
Mar-22-17 10:10AM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2017 By the Numbers : March 22, 2017 Capital Cube
10:10AM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2017 By the Numbers : March 22, 2017
Mar-17-17 01:56PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 10-Q, Quarterly Report
Mar-16-17 04:03PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
04:01PM  Champions Oncology Reports 40% Revenue Growth PR Newswire
09:00AM  Champions Oncology Announces Plan to Open New Lab Facility in Rockville, Maryland PR Newswire
07:07AM  Q3 2017 Champions Oncology Inc Earnings Release - After Market Close
Mar-07-17 08:00AM  Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 16, 2017 PR Newswire
Feb-16-17 09:36AM  Champions Oncology Announces New Collection of Patient-Derived Xenograft (PDX) Models Available for Translational Research PR Newswire
Jan-26-17 01:29PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jan-19-17 10:38AM  Champions Oncology Retains Hayden IR to Execute Comprehensive Investor Relations Program PR Newswire +7.56%
Dec-16-16 08:34AM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q2, 2017 By the Numbers : December 16, 2016 Capital Cube
08:34AM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q2, 2017 By the Numbers : December 16, 2016
Dec-14-16 04:08PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 10-Q, Quarterly Report -7.08%
06:53AM  How Champions Oncology Inc (CSBR) Stacks Up Against Its Peers Insider Monkey
06:53AM  How Champions Oncology Inc (CSBR) Stacks Up Against Its Peers at Insider Monkey
Nov-29-16 04:16PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Pr
04:15PM  Champions Oncology Reports 50% Revenue Growth, Accelerated Progress on Path to Profitability and Future Role Changes of the Senior Leadership PR Newswire
07:07AM  Q2 2017 Champions Oncology Inc Earnings Release - After Market Close
Nov-23-16 10:20AM  Champions Oncology to Announce Second Quarter Financial Results on Tuesday, November 29, 2016 PR Newswire
Nov-17-16 04:05PM  Champions Oncology Signs $2 million Contract PR Newswire
Nov-16-16 07:05PM  Champions Oncology Inc (CSBR) Stock: Have We Met? at Insider Monkey -8.47%
Nov-15-16 02:27PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Delaware Law by Certain Officers and Directors of Champions Oncology, Inc. Business Wire
Nov-01-16 12:06PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Oct-25-16 08:59AM  Insider Selling at Dominos Pizza Inc. (DPZ) and Intel Corporation (INTC), Plus Insider Buying at Three Other Companies at Insider Monkey
Oct-14-16 01:12PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Oct-12-16 06:56AM  Notable Insider Selling at Applied Materials Inc. (AMAT) and Costco Wholesale (COST), Plus Insider Moves at 3 Other Companies at Insider Monkey
Sep-14-16 03:09PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 10-Q, Quarterly Report
Sep-13-16 09:54AM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q1, 2017 By the Numbers : September 13, 2016
Sep-09-16 08:16AM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
08:15AM  Champions Oncology Beats Revenue Guidance for Quarter; Reaffirms Full Year Guidance of 43 - 60% Revenue Growth PR Newswire
07:07AM  Q1 2017 Champions Oncology Inc Earnings Release - Before Market Open
Sep-06-16 08:30AM  Champions Oncology to Announce First Quarter Financial Results on Friday, September 9, 2016 PR Newswire
Jul-29-16 01:11PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 10-K, Annual Report
Jul-28-16 08:00AM  Champions Oncology Announces Revenue Up 26%, Projects 43% - 60% Growth For Current Fiscal Year PR Newswire
07:53AM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
07:07AM  Q4 2016 Champions Oncology Inc Earnings Release - Before Market Open
Jul-25-16 06:18PM  Champions Oncology to Announce Year-End 2016 Financial Results on Thursday, July 28, 2016 PR Newswire
Jul-22-16 04:10PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
Jul-18-16 08:30AM  Champions Oncology Successfully Delivers First AML Study PR Newswire
Jun-15-16 04:33PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stat
12:00PM  Champions Oncology, Inc. Announces Closing of Public Offering of Common Stock PR Newswire
Jun-09-16 07:30PM  Champions Oncology, Inc. Announces Pricing of Public Offering of Common Stock PR Newswire
May-23-16 11:07AM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2016 By the Numbers : May 23, 2016
May-18-16 05:15PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Apr-13-16 04:01PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial State
Apr-12-16 12:30PM  Champions Oncology Announces Addition to Board of Directors PR Newswire
Mar-25-16 03:02PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St
Mar-22-16 11:06AM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2016 By the Numbers
Mar-16-16 10:03AM  CHAMPIONS ONCOLOGY, INC. Files SEC form 10-Q, Quarterly Report
Mar-15-16 08:31AM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
08:30AM  Champions Oncology Reports Results for the Third Quarter Ended January 31, 2016 PR Newswire
07:07AM  Q3 2016 Champions Oncology Inc Earnings Release - Before Market Open
Mar-11-16 09:00AM  Champions To Present at the 28th Annual ROTH Capital Conference on March 16, 2016 PR Newswire
Mar-10-16 10:00AM  Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2016 PR Newswire
Mar-07-16 05:15PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-21-16 11:00AM  Champions Oncology Announces Initiation of Prospective Correlative Trial in Sarcoma PR Newswire
Dec-24-15 11:02AM  Champions Oncology, Inc. Earnings Analysis: Q2, 2016 By the Numbers
Dec-15-15 05:23PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 10-Q, Quarterly Report
Dec-14-15 04:50PM  Champions Oncology Reports Results for the Second Quarter Ended October 31, 2015 PR Newswire
04:35PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
04:01PM  Champions Oncology Leading Paradigm Shift to Incorporation of PDX Models into Clinical Trial Strategy PR Newswire
07:07AM  Q2 2016 Champions Oncology Inc Earnings Release - After Market Close
Dec-10-15 10:45AM  Champions Oncology to Announce Second Quarter Financial Results on Monday, December 14, 2015 PR Newswire
Nov-30-15 11:51AM  Champions Oncology to Present at LD MICRO Investor Conference PR Newswire
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The company also offers POS products, including personalized tumor boards that are designed to provide access to oncologists with expertise in particular tumor types; and provides access to gene sequencing that analyzes the genetic makeup of patient's tumor for the purpose of identifying potentially useful drugs. In addition, it offers Translational Oncology Solutions (TOS), including a preclinical Tumorgraft platform to pharmaceutical and biotechnology companies that use vivo studies, which rely on implanting multiple tumors from TumorBank in mice and testing the therapy of interest on tumors. The company markets its products through Internet, word of mouth, and a network of sales force to patients and physicians. Champions Oncology, Inc. has collaboration agreements with The Addario Lung Cancer Medical Institute and AstraZeneca to develop cohorts of PDX models. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011 to reflect its new focus on developing technologies to personalize the development and use of oncology drugs. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morris RonnieCEOMar 27Buy3.622,3008,3191,116,582Mar 28 05:26 PM
Morris RonnieCEOMar 26Buy3.572,2357,9791,114,282Mar 28 05:26 PM
Morris RonnieCEOMar 23Buy3.504401,5401,111,847Mar 26 04:05 PM
Morris RonnieCEOMar 22Buy3.492609071,112,047Mar 26 04:05 PM